13F filer · CIK 1377452
Visium Asset Management, LP
New York, NY · filing since Q2 2013 · last filing Feb 14, 2017
Reported value
$1.4B
$-4.4B vs prior
Positions
333
New / sold out
145 / 287
Added / reduced
30 / 151
Turnover
19.8%
buys $722.5M · sells $5.2B
Top-10 weight
25.3%
Biggest buys vs Q1 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | LinkedIn CorpCALL | +420,900 | – | +$79.7M |
| Added | Teva Pharmaceutical Industries LtdCALL | +1,243,600 | +808.1% | +$62.5M |
| New | Monsanto CoCALL | +281,600 | – | +$29.1M |
| New | Marathon Petroleum Corp | +674,173 | – | +$25.6M |
| New | Barrick Gold CorpCALL | +1,190,300 | – | +$25.4M |
| Added | Endo International PLCCALL | +1,488,300 | +421.0% | +$23.2M |
| New | KBR Inc | +1,701,291 | – | +$22.5M |
| New | CF Corp | +2,009,300 | – | +$19.9M |
| Added | Eldorado Gold CorpCALL | +3,894,100 | +229.6% | +$17.5M |
| New | United States Steel CorpPUT | +950,600 | – | +$16.0M |
165 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | Laboratory Corp of America Holdings | -2,393,525 | -100.0% | $-280.4M |
| Reduced | Allergan plc | -983,063 | -99.8% | $-226.7M |
| Sold out | Pacira Pharmaceuticals Inc/DE | -2,239,098 | -100.0% | $-118.6M |
| Reduced | Endo International PLC | -6,668,686 | -99.8% | $-103.9M |
| Sold out | Centene Corp | -1,683,727 | -100.0% | $-103.7M |
| Sold out | Biogen Inc | -381,642 | -100.0% | $-99.3M |
| Reduced | Neurocrine Biosciences Inc | -1,859,385 | -99.7% | $-84.2M |
| Sold out | Zeltiq Aesthetics Inc | -2,871,762 | -100.0% | $-78.0M |
| Reduced | Pfizer Inc | -2,139,412 | -99.7% | $-75.5M |
| Sold out | Healthcare Trust of America Inc | -2,382,215 | -100.0% | $-70.1M |
428 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2016
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | LinkedIn CorpCALLCOMMON STOCK | 420,900 | $79.7M | 5.57% |
| 2 | Teva Pharmaceutical Industries LtdCALLCOMMON STOCK | 1,397,500 | $70.2M | 4.91% |
| 3 | Randgold Resources LtdCALLCOMMON STOCK | 291,800 | $32.7M | 2.29% |
| 4 | Monsanto CoCALLCOMMON STOCK | 281,600 | $29.1M | 2.04% |
| 5 | Endo International PLCCALLCOMMON STOCK | 1,841,800 | $28.7M | 2.01% |
| 6 | Marathon Petroleum CorpCOMMON STOCK | 674,173 | $25.6M | 1.79% |
| 7 | Barrick Gold CorpCALLCOMMON STOCK | 1,190,300 | $25.4M | 1.78% |
| 8 | Eldorado Gold CorpCALLCOMMON STOCK | 5,590,200 | $25.2M | 1.76% |
| 9 | Yahoo! IncCOMMON STOCK | 599,853 | $22.5M | 1.58% |
| 10 | KBR IncCOMMON STOCK | 1,701,291 | $22.5M | 1.58% |
323 more rows. Subscribe for $29/month to see every row, download the data and use the API.